Around 5% of US Population Diagnosed With Autoimmune DiseaseJanuary 14, 2025Rare DiseasesEndocrinologyDermatologyGastroenterologyImmunologyNeurologyRheumatology
Alpha-Gal Syndrome: 5 Things to KnowDecember 19, 2024ImmunologyDermatologyGastroenterologyPreventive CareRare Diseases
Health Impacts of Micro- and NanoplasticsDecember 17, 2024EndocrinologyPulmonologyWomen's HealthNeurologyHepatologyRare Diseases
Real-World Data Question Low-Dose Steroid Use in ANCA VasculitisDecember 9, 2024RheumatologyNephrologyRare Diseases
Need for Low-Dose Steroids to Prevent Relapse in GPA Vasculitis Depends on Treatment RegimenNovember 18, 2024Rare DiseasesRheumatologyNephrologyPulmonology
First Phase 3 Drug Trial in IgG4-Related Disease Has SuccessNovember 18, 2024NephrologyGastroenterologyNeurologyRheumatologyRare DiseasesPulmonology
Scurvy: A Diagnosis Still Relevant TodayNovember 8, 2024GastroenterologyRare DiseasesDermatologyAnemiaHematologyRheumatologyNeurology
Benralizumab Now FDA Approved to Treat EGPA VasculitisSeptember 19, 2024Rare DiseasesRheumatologyNephrologyPulmonologyAsthma
Neurofibromatosis: What Affects Quality of Life Most?September 4, 2024Rare DiseasesDermatologyMental HealthMixed Topics
Dermatofibrosarcoma Protuberans More Common In Black Patients, Analysis FindsJuly 2, 2024Rare DiseasesDiversity in MedicineDermatologyOncology
Pyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Rare DiseasesMusculoskeletal DisordersDermatologyRheumatologyGastroenterology
‘Therapeutic Continuums’ Guide Systemic Sclerosis Treatment in Updated EULAR RecommendationsJune 26, 2024Rare DiseasesDermatologyRheumatology
Sex-Related Differences Found in IgG4-Related Disease EpidemiologyJune 24, 2024Rare DiseasesPulmonologyRheumatologyNeurology
